Abstract:Background Ulcerative colitis (UC) is an inflammatory bowel disease characterized by idiopathic and recurrent mucosal inflammation [1]. The pathogenesis is multifactorial, involving genetic susceptibility, epithelial barrier defects, dysregulation of the immune response, and environmental factors. UC is a highly heterogeneous disease [2]. Despite efforts to characterize disease subgroups and predict differential outcomes in UC patients, disease heterogeneity is not adequately translated into current clinical subclassifications. Objectives This study seeks to unravel this complexity by using an integrated systems approach that classifies UC patients into different phenotypes based on the immune microenvironment, capable of providing new insights into the development of stratified therapies. Methods RNA sequencing datasets of 602 colon tissue samples from 455 patients with UC and 147 healthy controls (HC) was imported from GEO database. The microarray datasets were transformed into immune cell components by CIBERSORT, and patients were stratified by a consensus clustering algorithm. Then, the cellular characteristics of the subtypes and the overall role of specific pathways were determined by immune cell infiltration and pathway enrichment. The clinical characteristics of the different subtypes were also analyzed to clarify the characteristics of these classifications. Results Patients can be classified into two distinct immune phenotypes (Subtype A, B) based on their specific RIME, which have different cellular and pathway characteristics. (Figure A, B) The results show that Subtype A is mainly enriched in immune cells such as B cells, CD8+ T cells, CD4+ memory T cells, DC cells, macrophages, mast cells and plasma cells. Acidic granulocytes and neutrophils were more active in Subtype B. It was also significantly enriched in the peroxisome proliferator-activated receptor (PPAR) signaling pathway in Subtype B. In contrast, Subtype A showed a strong enrichment for most inflammatory pathways B cell and T cell receptor signaling, IL-17 signaling pathway, TNF, and interleukin 4 and interleukin 13 signaling pathway. (Figure 1 D, E) In addition, there was a significant difference between molecular subclassification and disease status, with Subtype A being more active in patients (69.3% of Subtype A vs.30.6% of Subtype B subtypes in 137 cases), while inactive patients, Subtype B were more prevalent (44.8% of Subtype A vs. 55.2% of Subtype B in 105 cases). (Figure 1C) Conclusion Analysis of the immune microenvironment of colonic mucosal tissue provides good insight into the pathophysiological characteristics of UC. These results can be used as a model for future studies. the response and clinical outcomes of patients with different classification need to be further investigated. References [1]Ghosh S, Shand A, Ferguson A. Ulcerative colitis. BMJ (Clinical research ed). 2000;320(7242):1119-23. [2]Ordás I, Eckmann L, Talamini M, Baumgart DC, Sandborn WJ. Ulcerative colitis. Lancet (London, England). 2012;380(9853):1606-19. Acknowledgements: NIL. Disclosure of Interests None Declared.

A molecular subtyping associated with the cGAS-STING pathway provides novel perspectives on the treatment of ulcerative colitis

Identification of Crucial Genes and Related-Transcription Factors in Ulcerative Colitis

Identification of Differential Intestinal Mucosa Transcriptomic Biomarkers for Ulcerative Colitis by Bioinformatics Analysis

Identification of subclusters and prognostic genes based on GLS-associated molecular signature in ulcerative colitis

Single-Cell RNA-Sequencing Analysis of Colonic Lamina Propria Immune Cells Reveals the Key Immune Cell-Related Genes of Ulcerative Colitis

Identification and experimental validation of immune-related gene PPARG is involved in ulcerative colitis

Identification of Immune-Related Gene Signature and Prediction of CeRNA Network in Active Ulcerative Colitis

Bioinformatics Analysis of Key Candidate Genes and Pathways in Ulcerative Colitis

Integrated Analysis of Multiple Microarray Studies to Identify Novel Gene Signatures in Ulcerative Colitis

PANoptosis and Autophagy-Related Molecular Signature and Immune Landscape in Ulcerative Colitis: Integrated Analysis and Experimental Validation

Identification of Differentially Expressed Genes, Associated Functional Terms Pathways, and Candidate Diagnostic Biomarkers in Inflammatory Bowel Diseases by Bioinformatics Analysis.

Exploring Immune Cell Infiltration and Small Molecule Compounds for Ulcerative Colitis Treatment

Identification of differentially expressed genes in ulcerative colitis and verification in a colitis mouse model by bioinformatics analyses

AB1675 DEEP PHENOTYPING OF IMMUNE MICROENVIRONMENT IN ULCERATIVE COLITIS BY INTEGRATIVE SYSTEMS ANALYSIS

Identifying neutrophil-associated subtypes in ulcerative colitis and confirming neutrophils promote colitis-associated colorectal cancer

IBD Subtype-Regulators IFNG and GBP5 Identified by Causal Inference Drive More Intense Innate Immunity and Inflammatory Responses in CD Than Those in UC

Single-cell and microarray chip analysis revealed the underlying pathogenesis of ulcerative colitis and validated model genes in diagnosis and drug response

Integrated Strategy of Differentially Expressed Genes Associated with Ulcerative Colitis

AB0544 PHENOTYPING ON MUCOSAL MOLECULAR SIGNITURE OF PATIENTS WITH ULCERATIVE COLITIS ANALYSIS

Unveiling the key genes, environmental toxins, and drug exposures in modulating the severity of ulcerative colitis: a comprehensive analysis

Identification of Differentially Expressed Genes and miRNAs for Ulcerative Colitis Using Bioinformatics Analysis